| Ticker Details |
|
MIRUM PHARMACEUTICALS, INC.
|
| IPO Date: |
July 12, 2019 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$5.87B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.87 | 2.76%
|
| Avg Daily Range (30 D): |
$3.15 | 2.97%
|
| Avg Daily Range (90 D): |
$2.70 | 2.56%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.32M |
| Avg Daily Volume (30 D): |
.54M |
| Avg Daily Volume (90 D): |
.68M |
| Trade Size |
| Avg Trade Size (Sh.): |
57 |
| Avg Trade Size (Sh.) (30 D): |
46 |
| Avg Trade Size (Sh.) (90 D): |
53 |
| Institutional Trades |
| Total Institutional Trades: |
2,564 |
| Avg Institutional Trade: |
$3.74M |
| Avg Institutional Trade (30 D): |
$4.36M |
| Avg Institutional Trade (90 D): |
$6.23M |
| Avg Institutional Trade Volume: |
.07M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$4.94M |
| Avg Closing Trade (30 D): |
$9.41M |
| Avg Closing Trade (90 D): |
$14.49M |
| Avg Closing Volume: |
92.53K |
|
|
| Financials |
| |
TTM |
Q2 2026 |
Q1 2026 |
|
Basic EPS
|
$-14.55
|
$-1.06
|
$-13.43
|
|
Diluted EPS
|
$-14.56
|
$-1.06
|
$-13.43
|
|
Revenue
|
$618.07M
|
$176.24M
|
$159.88M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-860.21M
|
$-67.23M
|
$-790.16M
|
|
Operating Income / Loss
|
$-833.97M
|
$-42.54M
|
$-789.47M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$106.56M
|
$7.2M
|
$29.75M
|
|
PE Ratio
|
|
|
|
|
|
|